It has recently been reported that overexpression of MYC and BCL2 predicts a poor prognosis in patients with extranodal NK/T-cell lymphoma (NKTL) of the nasal type [38]. This evidence concerns the gene BCL2 and extranodal nasal NK/T cell lymphoma.